RNS Announcement
The Schiehallion Fund
Limited
Legal Entity Identifier: 213800NQOLJA1JCWXQ56
Regulated Information Classification: Interim Financial
Report
The following is the unaudited Interim
Financial Report for the six months to 31 July 2024 which was
approved by the Board on 12 September 2024.
Board update
David Chiswell resigned as non-executive
Director of the Company in April 2024 due to ongoing health issues
and has sadly since passed away. David made a significant
contribution to the Board during his tenure and was an effective
and widely admired Director who will be much missed by the Board
and the Managers. David held positions across the biotechnology
industry and his contributions to the field were recognised in 2006
when he was awarded the OBE by The Queen for services to the
industry.
The Directors recognise the importance of
succession planning and review the Board composition annually. The
Board is committed to maintaining the Board's depth and breadth of
knowledge, experience and professional expertise. The Board will
communicate future succession plans in due course.
During the period, the Board engaged with the
relevant shareholder following the significant number of votes
against the re-appointment of Dr Yueh at the Annual General Meeting
on 10 May 2024. The shareholder's concerns related to the number of
simultaneous directorships. A review of the Chair's and other
Directors' commitments was carried out and the Nomination Committee
remains satisfied that Dr Yueh is capable of devoting sufficient
time to the Company. There have been no significant changes to Dr
Yueh's other commitments since 31 January 2024. Her total number of
mandates from her directorships continues to comply with the UK
Corporate Governance Code. The Directors continue to believe that
the Board has a balance of skills and experience which enable it to
provide effective strategic leadership and proper governance of the
Company.
Summary of unaudited results*
Ordinary
shares
|
31 July 2024
|
31 January 2024
(audited)
|
% change
|
Shareholders' funds
|
US$1,178.17m
|
US$1,219.14m
|
|
Net asset value per Ordinary share
|
114.61¢
|
118.37¢
|
(3.2%)
|
Share price
|
103.00¢
|
71.50¢
|
44.1%
|
Discountâ€
|
10.1%
|
39.6%
|
|
Number of shares in issue
|
1,027,973,907
|
1,029,898,907
|
|
Market capitalisation
|
US$1,058.81m
|
US$736.38m
|
|
|
Six months to
31 July 2024
|
Six months to
31 July 2023
|
Revenue earnings per Ordinary share
|
(0.04¢)
|
(0.30¢)
|
Period's high and low
|
Six months to
31 July 2024
|
For the period
1 February 2023 to 8 September 2023
|
For the period
9 September 2023 to 31 January 2024
|
Ordinary
shares
|
High
|
Low
|
High
|
Low
|
High
|
Low
|
Net asset value per Ordinary share
|
120.57¢
|
114.61¢
|
117.98¢
|
103.94¢
|
118.66¢
|
103.40¢
|
Share price
|
103.00¢
|
57.00¢
|
92.50¢
|
59.00¢
|
74.00¢
|
45.00¢
|
Discountâ€
|
(11.66%)
|
(51.23%)
|
(22.53%)
|
(44.93%)
|
(36.29%)
|
(56.48%)
|
Notes
* For
a definition of terms see Glossary of terms and Alternative
Performance Measures at the end of this announcement.
â€
Alternative Performance Measure, see Glossary of terms and
Alternative Performance Measures at the end of this
announcement.
All investment strategies have the potential
for profit and loss. Past performance is not a guide to future
performance.
Investment objective
The Schiehallion Fund Limited seeks to generate
capital growth for investors through making long-term minority
investments in later stage private businesses that the Company
considers to have transformational growth potential and to have the
potential to become publicly traded.
Principal risks and uncertainties
The principal and emerging risks facing the
Company are:
Investment and
strategic risks - liquidity of investments;
market, economic, political and environmental risks; valuation
risk; investment strategy risk; discount risk; and Environmental,
Social and Governance ('ESG') risk.
External
risks - political and associated economic risk;
legal and regulatory risk.
Operational
risks - performance and reliance on third party
service providers; cyber security threats; and key
professionals.
Emerging
risks - geopolitical tensions, including the
Russia-Ukraine conflict and US-China tensions, high energy prices,
inflation and interest rates; cyber risk; and the proliferation of
AI technology.
An explanation of these risks and how they are
managed is set out on pages 39 to 44 of the Company's Annual Report
and Financial Statements for the year to 31 January 2024 which
is available on the Company's website: schiehallionfund.com
Responsibility statement
The Directors of The Schiehallion Fund Limited
confirm that to the best of their knowledge:
a. the
Interim Financial Report has been prepared in accordance with IAS
34 Interim Financial Reporting and the Directors have elected to
prepare financial statements that comply with International
Financial Reporting Standards as issued by the International
Accounting Standards Board;
b. the
Interim Management Report includes a fair review of the information
required by:
i.
DTR 4.2.7R of the Disclosure Guidance and Transparency Rules, being
an indication of important events that have occurred during the
first six months of the financial year and their impact on the
condensed set of financial statements, and a description of the
principal risks and uncertainties for the remaining six months of
the financial year; and
ii. DTR
4.2.8R of the Disclosure Guidance and Transparency Rules, being
related party transactions that have taken place in the first six
months of the current financial year and that have materially
affected the financial position or the performance of the
enterprise during that period.
On behalf of the Board
Dr Linda Yueh CBE
Chairperson
12 September 2024
The Directors are responsible for the
maintenance and integrity of the corporate and financial
information included on the Company's website, and for the
preparation and dissemination of financial statements. Legislation
in Guernsey governing the preparation and dissemination of
financial statements may differ
from legislation in other jurisdictions.
Interim management report
The six months to 31 July 2024 saw NAV
total return down 3.2%. However, the share price increased by 44.1%
over the period, causing the discount to narrow to
10.1%.
Both private and public holdings contributed to
the NAV decrease. On the public side, key negative contributors
were buy-now pay-later provider Affirm and foreign exchange
platform Wise. Affirm's share price dropped 42% and Wise's dropped
17%. Underlying operational performance at both companies was still
strong. Affirm saw 51% revenue growth and achieving over one
million users of its Affirm Card product, whilst Wise grew revenues
23% and more than tripled profits. Over the life of the fund, both
stocks remain strong net contributors to performance. On the
private side, German real estate broker McMakler was the main
negative contributor, as it continues to battle macroeconomic
headwinds in the domestic property market.
Positive contributors included Italian consumer
digital application company Bending Spoons and American expense
management and credit card company Brex. Bending Spoons has
continued to deliver strong operational performance and show signs
of having successfully integrated its recent acquisitions. We added
more to our position reflecting growing conviction in the
investment case. Brex has posted stronger operational results and
improved margins as it gains efficiency following a difficult
workforce reduction exercise.
Across the portfolio,
operating performance remains broadly strong. Portfolio-weighted
revenue growth was 41% over the period, with 39% of the companies
by portfolio weighting being EBITDA-positive, and nearly 50% of
companies in total being cash generative. The vast majority of the
companies within the portfolio have cash balances greater than a
year, with just under 5% having less than 12 months cash
runway.
Portfolio management
Over the six months to 31 July, we made
one new investment and completed two sales.
The new investment was in Tekever. Tekever is a
Portuguese aerial intelligence company. It produces
software-defined autonomous surveillance drones for both non-lethal
military and civilian use cases.
The sales were of public company Allbirds and
private company Graphcore. Footwear company Allbirds had struggled
to expand its customer base and product reach since its IPO, with a
couple of false starts into apparel and high-performance footwear.
We felt the capital could be better used elsewhere in our
opportunity set. AI semiconductor design company Graphcore was
acquired by Softbank. Despite having had setbacks in customer
contracts and chip developments, at the sale price we were able to
recoup the majority of our initial investment. Nonetheless, neither
of these sales represent the kinds of outcomes that we
seek.
We had one holding IPO in the period. Tempus
AI, owner of one of the world's biggest libraries of clinical and
molecular data, listed at a 20% premium to its end-of-May carrying
valuation. The period also saw further private capital raising
activity, with autonomous driving software company Wayve receiving
a large investment from Softbank, Nvidia and Microsoft. We first
took a position in Wayve for the fund in January 2022.
We have continued to execute on the share
buyback program announced in November 2023. To 31 July 2024, the
fund has bought back 4,526,000 shares. We will continue to allocate
the remaining 12% of capital across new private opportunities,
supporting existing companies and buying back shares.
Private company valuations
Over the reporting period, there were 170
revaluation events, with ~45% of the portfolio being revalued three
times or more. The average movement at the private company level
was -6.3%.
The gradual uptick in private markets activity
over the past twelve months have given us opportunities to compare
our carrying valuations with external price discovery moments. Over
the last year, we have seen eleven such price discovery events. On
nine occasions we needed to revalue our holdings up, with a median
upwards revaluation of 18%. On two occasions we needed to revalue
our holdings down, with a median downwards revaluation of
2%.
As a reminder of our valuation process, we aim
for a targeted +/- 20% range to the new valuation, with some
balance of being over and under - neither consistently conservative
nor consistently bullish. The overall median movement over the
twelve months has been an increase of 16%, giving us comfort over
the fair value positions and their proximity to eventual
transaction events.
Looking forward
We continue to see causes for optimism in the
underlying holdings. The companies within the fund have reacted
well to a tough couple of years in private markets, and we believe
are well positioned to continue to take advantage of their
competitive positions in the years ahead. We have been continuing
to invest in our capability at Baillie Gifford, with four more
investors joining our team during the period.
More and more excellent companies are coming
back to the market to organise rounds - if not for their own
primary capital needs, then to facilitate liquidity for their early
venture backers, who are coming under pressure for liquidity from
their own clients. The result is a much healthier crop of
interesting companies raising capital than we have seen for the
last couple of years. We believe the share price appreciation over
the last six months hints at an improved sentiment in general
towards growth equity in the markets. If so, it is a sentiment we
share.
Peter Singlehurst
Robert Natzler
Portfolio executive summary
Performance
|
6 months
%
|
1 year
%
|
3 years
%
|
Since inception
% *
|
Share price
|
44.1%
|
56.1%
|
(49.3%)
|
(8.4%)
|
NAV
|
(3.2%)
|
4.7%
|
(30.2%)
|
15.0%
|
*
Inception date: 27 March 2019.
All figures are stated on a total return basisâ€
for periods to 31 July 2024.
â€
Alternative Performance Measure - see Glossary of terms and
Alternative Performance Measures at the end of this
announcement.
Source: Baillie Gifford/LSEG. See disclaimer at
the end of this announcement.
Key contributors to and detractors from Company
performance - six months to 31 July 2024
Contributorsâ€
|
Absolute return *
(%)
|
Tempus AI§
|
32.6
|
Bending Spoons
|
13.7
|
Space Exploration Technologies
|
7.8
|
Brex
|
15.0
|
HeartFlow
|
57.2
|
Detractorsâ€
|
Absolute return *
(%)
|
McMakler GmbH
|
(96.9)
|
Affirm§
|
(30.2)
|
Northvolt
|
(21.9)
|
Flix SE
|
(22.9)
|
Wise§
|
(10.8)
|
*
Absolute performance (in US$ terms) has been calculated on a total
return basis (including reinvestment of any dividends paid by
portfolio holdings) over the period 1 February 2024 to
31 July 2024.
†The
contributors to and detractors from Company performance are listed
in descending order.
§
Denotes listed investment previously held in the portfolio as a
private company investment.
Source: Revolution.
Distribution of total net assets
(unaudited)
Geographical as at 31 July
2024
|
Geographical
|
% at
31 July
2024
|
% at
31 January
2024
|
Number of
investments
at 31 July
2024
|
1
|
United States
|
54.2
|
50.7
|
30
|
2
|
China
|
8.0
|
7.7
|
3
|
3
|
United Kingdom
|
7.6
|
8.4
|
2
|
4
|
Italy
|
5.7
|
4.0
|
1
|
5
|
India
|
3.0
|
3.4
|
1
|
6
|
Germany
|
2.3
|
5.8
|
2
|
7
|
Sweden
|
2.1
|
2.7
|
1
|
8
|
Portugal
|
1.8
|
-
|
1
|
9
|
Australia
|
1.6
|
1.8
|
1
|
10
|
Brazil
|
0.8
|
0.9
|
1
|
11
|
Canada
|
<0.1
|
0.2
|
1
|
12
|
Net current assets
|
12.9
|
14.4
|
|
Sectoral as at 31 July 2024
|
Sectoral
|
% at
31 July
2024
|
% at
31 January
2024
|
Number of
investments
at 31 July
2024
|
1
|
Information technology
|
25.8
|
21.3
|
13
|
2
|
Industrials
|
15.4
|
13.0
|
6
|
3
|
Financials
|
15.3
|
18.0
|
5
|
4
|
Consumer discretionary
|
9.5
|
10.1
|
6
|
5
|
Communication services
|
8.9
|
8.8
|
3
|
6
|
Healthcare
|
4.7
|
3.6
|
4
|
7
|
Consumer staples
|
3.8
|
4.2
|
4
|
8
|
Materials
|
2.8
|
2.6
|
1
|
9
|
Real estate
|
0.9
|
4.0
|
2
|
10
|
Net current assets
|
12.9
|
14.4
|
|
The above sectoral distribution is not derived
from any index.
Baillie Gifford - valuing private companies
We aim to hold our private company investments
at 'fair value', i.e. the price that would be paid in an
open-market transaction. Valuations are adjusted both during
regular valuation cycles and on an ad hoc basis in response to
'trigger events'. Our valuation process ensures that private
companies are valued in both a fair and timely manner.
The valuation process is overseen by a
valuations group at Baillie Gifford, which takes advice from an
independent third party (S&P Global). The valuations group is
independent from the investment team with all voting members being
from different operational areas of the firm, and the investment
managers only receive final valuation notifications once they have
been applied.
We revalue the private holdings on a
three-month rolling cycle, with one-third of the holdings
reassessed each month. During stable market conditions, and
assuming all else is equal, each investment would be valued four
times in a twelve-month period. For Schiehallion and our investment
trusts, the prices are also reviewed twice per year by the
respective boards and are subject to the scrutiny of external
auditors in the annual audit process.
Beyond the regular cycle, the valuations team
also monitors the portfolio for certain 'trigger events'. These may
include changes in fundamentals, a takeover approach, an intention
to carry out an Initial Public Offering ('IPO'), company news which
is identified by the valuation team or by the portfolio managers,
or meaningful changes to the valuation of comparable public
companies. Any ad hoc change to the fair valuation of any holding
is implemented swiftly and reflected in the next published net
asset value ('NAV'). There is no delay.
The valuations team also monitors relevant
market indices on a weekly basis and updates valuations in a manner
consistent with our external valuer's (S&P Global) most recent
valuation report where appropriate.
Generally speaking, public markets have
continued to be less volatile in the six months to 31 July
2024, and overall, an improvement in market conditions has led to
an increase in private market deal activity. The data below
quantifies the revaluations carried out during the six months to
31 July 2024, however, it does not reflect the ongoing
monitoring of the private investment portfolio which has not
resulted in a change in valuation.
The Schiehallion
Fund*
|
|
Instruments held
|
68
|
Percentage of portfolio revalued up to 2
times
|
55.9%
|
Percentage of portfolio revalued 3+
times
|
44.1%
|
*
Data reflecting period 1 February 2024 to 31 July
2024.
List of investments
as at 31 July 2024 (unaudited)
Name
|
Business
|
Country
|
2024
Total value US$'000
|
2024
% of net
assets *
|
Space Exploration Technologies
|
Designs, manufactures and launches advanced
rockets and spacecraft
|
United States
|
95,248
|
8.1
|
ByteDance
|
Social media and news aggregation
company
|
China
|
68,518
|
5.8
|
Bending Spoons
|
Mobile application software
developer
|
Italy
|
66,970
|
5.7
|
Wise§
|
Online platform to send and receive
money
|
UK
|
55,336
|
4.7
|
Brex
|
Corporate credit cards for startups
|
United States
|
46,251
|
3.9
|
Affirm§
|
Online platform which provides point of sale
consumer finance
|
United States
|
36,717
|
3.1
|
Dailyhunt (VerSe Innovation)
|
Telephone voice, data, text messaging, and
roaming services
|
India
|
35,636
|
3.0
|
Tempus AI§
|
Oncological records aggregator and diagnostic
testing provider
|
United States
|
35,029
|
3.0
|
Wayve Technologies
|
AI based software for self-driving
cars
|
UK
|
34,297
|
2.9
|
Solugen
|
Combines enzymes and metal catalysts to make
chemicals
|
United States
|
33,030
|
2.8
|
Stripe
|
Online payment platform
|
United States
|
32,618
|
2.7
|
Databricks
|
Data software solutions
|
United States
|
30,488
|
2.6
|
Chime Financial
|
Digital current account provider
|
United States
|
27,314
|
2.4
|
Faire Wholesale
|
Online wholesale marketplace
|
United States
|
27,153
|
2.3
|
Flix SE
|
European mobility provider
|
Germany
|
25,435
|
2.2
|
Northvolt
|
Lithium ion battery manufacturer
|
Sweden
|
24,147
|
2.1
|
Grammarly
|
Online platform for checking grammar, spelling
and improving written communication
|
United States
|
23,521
|
2.0
|
Kepler Computing
|
Semiconductor company
|
United States
|
23,137
|
2.0
|
Epic Games
|
Video game developer
|
United States
|
22,263
|
1.9
|
Rappi
|
Provider of an on-demand delivery platform
designed to connect consumers with local stores
|
United States
|
22,091
|
1.9
|
Tekever
|
Unmanned systems technology and services
manufacturer
|
Portugal
|
21,641
|
1.8
|
Warby Parker§
|
Online and physical corrective eyewear
retailer
|
United States
|
21,199
|
1.8
|
Pet Circle (Millell Pty Ltd)
|
Pet food and accessories
|
Australia
|
18,881
|
1.6
|
Oddity§
|
Direct to consumer cosmetics
|
United States
|
18,804
|
1.6
|
Genki Forest Technology Group
|
Non-alcoholic beverages
|
China
|
18,700
|
1.6
|
HeartFlow
|
Develops software for cardiovascular disease
diagnosis and treatment
|
United States
|
16,055
|
1.3
|
PsiQuantum
|
Silicon photonic quantum computing
|
United States
|
14,985
|
1.3
|
Tanium
|
Online security management
|
United States
|
14,649
|
1.2
|
Merlin Labs
|
Autonomous flight technology
|
United States
|
14,625
|
1.2
|
Oscar Health§
|
Healthcare insurance provider
|
United States
|
14,534
|
1.2
|
Nuro
|
Developer of autonomous delivery
vehicles
|
United States
|
14,287
|
1.2
|
Cohesity
|
Data storage
|
United States
|
11,302
|
1.0
|
Workrise Technologies
|
Jobs marketplace for the energy
sector
|
United States
|
10,967
|
0.9
|
Airbnb§
|
Online market place for travel
accommodation
|
United States
|
10,730
|
0.9
|
Loft
|
Online property platform
|
Brazil
|
9,078
|
0.8
|
AWAY (JRSK Inc)
|
Travel and lifestyle brand
|
United States
|
8,567
|
0.8
|
Jiangxiaobai
|
Producer of alcoholic beverages
|
China
|
7,000
|
0.6
|
Carbon
|
Manufactures and develops 3D
printers
|
United States
|
6,516
|
0.6
|
Honor Technology
|
Provider of home-care services
|
United States
|
4,754
|
0.4
|
MasterClass (Yanka Industries)
|
Online education subscription
platform
|
United States
|
1,387
|
0.1
|
McMakler GmbH
|
Real estate services
|
Germany
|
1,166
|
0.1
|
Illumina CVR
|
Gene sequencing equipment and
consumables
|
United States
|
407
|
<0.1
|
Indigo Agriculture
|
Microbial seed treatments to increase crop
yields and grain marketplace
|
United States
|
380
|
<0.1
|
Blockstream
|
Financial software developer
|
Canada
|
316
|
<0.1
|
Total
investments
|
|
|
1,026,129
|
87.1
|
Name
|
2024
Total value US$'000
|
2024
% of net
assets*
|
US Treasury Bill 20/03/2025
|
22,556
|
2.0
|
US Treasury Bill 15/05/2025
|
22,537
|
1.9
|
US Treasury Bill 05/09/2024
|
22,536
|
1.9
|
US Treasury Bill 23/01/2025
|
22,513
|
1.9
|
US Treasury Bill 29/11/2024
|
22,510
|
1.9
|
US Treasury Bill 31/10/2024
|
22,504
|
1.9
|
Total US
Treasury Bills
|
135,156
|
11.5
|
Cash
|
19,293
|
1.6
|
Other current assets and liabilities
|
(2,061)
|
(0.2)
|
Capital gains tax provisionâ€
|
(346)
|
<0.0
|
Net current
assets less capital gains tax provision
|
152,042
|
12.9
|
Total net
assets less capital gains tax provision
|
1,178,171
|
100.0
|
§
Denotes listed investment previously held in the portfolio as a
private company investment.
* See
Glossary of terms and Alternative Performance Measures at the end
of this announcement.
†The
tax liability provision at 31 July 2024 relates to a potential
liability for Indian capital gains tax that may arise on the
Company's Indian investments should they be sold in the future,
based on the net unrealised taxable capital gain at the period end
and on enacted Indian tax rates.
Name
|
Listed
investments
%
|
Private
company
investments
%
|
Net current
assets *
%
|
Net assets *
%
|
31 July 2024
|
16.3
|
70.8
|
12.9
|
100.0
|
31 January 2024
|
14.3
|
71.3
|
14.4
|
100.0
|
Allocation of net assets (unaudited)
Name
|
2024
Total value US$'000
|
2024
% of net
assets *
|
Listed investments
|
192,349
|
16.3
|
Private company investments
|
833,373
|
70.8
|
Contingent value rights
|
407
|
<0.1
|
US Treasury Bills
|
135,156
|
11.5
|
Cash and cash equivalents
|
19,293
|
1.6
|
Net current assets
|
(2,407)
|
(0.2)
|
Total net
assets
|
1,178,171
|
100.0
|
* See
Glossary of terms and Alternative Performance Measures at the end
of this announcement.
The Company may hold various classes of shares
in investee companies, some of which may have a preference on
winding up.
Statement of comprehensive income (unaudited)
|
|
For the six months
to 31 July 2024
|
For the six months
to 31 July 2023
|
For the year to
31 January 2024
|
|
Notes
|
Revenue
US$'000
|
Capital
US$'000
|
Total
US$'000
|
Revenue
US$'000
|
Capital
US$'000
|
Total
US$'000
|
Revenue
US$'000
|
Capital
US$'000
|
Total
US$'000
|
(Losses)/gains on investments
|
|
-
|
(39,662)
|
(39,662)
|
-
|
(46,896)
|
(46,896)
|
-
|
69,768
|
69,768
|
Currency gains/(losses)
|
|
-
|
27
|
27
|
-
|
(9)
|
(9)
|
-
|
75
|
75
|
Income
|
2
|
4,670
|
-
|
4,670
|
3,512
|
-
|
3,512
|
8,211
|
-
|
8,211
|
Investment management fee
|
3
|
(4,471)
|
-
|
(4,471)
|
(3,937)
|
-
|
(3,937)
|
(8,152)
|
-
|
(8,152)
|
Other administrative expenses
|
4
|
(577)
|
-
|
(577)
|
(637)
|
-
|
(637)
|
(1,263)
|
-
|
(1,263)
|
Operating
(loss)/profit before finance costs and taxation
|
|
(378)
|
(39,365)
|
(40,013)
|
(1,062)
|
(46,905)
|
(47,967)
|
(1,204)
|
69,843
|
68,639
|
Finance cost of borrowings
|
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating
(loss)/profit before taxation
|
|
(378)
|
(39,635)
|
(40,013)
|
(1,062)
|
(46,905)
|
(47,967)
|
(1,204)
|
69,843
|
68,639
|
Tax on ordinary activities
|
|
-
|
486
|
486
|
-
|
-
|
-
|
-
|
(834)
|
(834)
|
(Loss)/profit
and total comprehensive (loss)/income for the
period
|
|
(378)
|
(39,149)
|
(39,527)
|
(1,062)
|
(46,905)
|
(47,967)
|
(1,204)
|
69,009
|
67,805
|
|
|
For the six months
to 31 July 2024
|
For the six months
to 31 July 2023
|
For the year to
31 January 2024
|
|
Notes
|
Revenue
US$'000
|
Capital
US$'000
|
Total
US$'000
|
Revenue
US$'000
|
Capital
US$'000
|
Total
US$'000
|
Revenue
US$'000
|
Capital
US$'000
|
Total
US$'000
|
Total
comprehensive (loss)/income for the period analysed as
follows:
|
|
|
|
|
|
|
|
|
|
|
Attributable to Ordinary
shareholders
|
5
|
(378)
|
(39,149)
|
(39,527)
|
(1,483)
|
(48,168)
|
(49,651)
|
(1,204)
|
69,009
|
67,805
|
Attributable to C shareholders*
|
5
|
|
|
|
421
|
1,263
|
1,684
|
|
|
|
(Loss)/profit
and total comprehensive (loss)/profit for the
period
|
|
(378)
|
(39,149)
|
(39,527)
|
(1,062)
|
(46,905)
|
(47,967)
|
(1,204)
|
69,009
|
67,805
|
(Loss)/earnings per Ordinary share
|
5
|
(0.04¢)
|
(3.81¢)
|
(3.85¢)
|
(0.30¢)
|
(9.62¢)
|
(9.92¢)
|
(0.12¢)
|
6.69¢
|
6.57¢
|
(Loss)/earnings per C share*
|
5
|
|
|
|
0.06¢
|
0.18¢
|
0.24¢
|
|
|
|
* The
Company's C shares converted into Ordinary shares on
8 September 2023 and therefore there is no C shares
income/(loss) to report for the six months to 31 July
2024 and the year to 31 January 2024.
The total column of this Statement represents
the Statement of Comprehensive Income of the Company.
The supplementary revenue and capital columns
are prepared under guidance published by the Association of
Investment Companies.
All revenue and capital items in this statement
derive from continuing operations.
The accompanying notes below are an integral
part of the Financial Statements.
Statement of financial position (unaudited)
|
Notes
|
At
31 July
2024
US$'000
|
At
31 July
2024
US$'000
|
At 31 January
2024
US$'000
|
At 31 January
2024
US$'000
|
Fixed
assets
|
|
|
|
|
|
Investments held at fair value through profit
or loss
|
7
|
|
1,026,129
|
|
1,043,781
|
Current
assets
|
|
|
|
|
|
US Treasury Bills
|
|
135,156
|
|
167,522
|
|
Cash and cash equivalents
|
|
19,293
|
|
11,306
|
|
Debtors
|
|
2,257
|
|
1,743
|
|
|
|
156,706
|
|
180,571
|
|
Current
liabilities
|
|
|
|
|
|
Amounts falling due within one year
|
|
(4,318)
|
|
(4,381)
|
|
Net current
assets
|
|
|
152,388
|
|
176,190
|
Non-current
liabilities
|
|
|
|
|
|
Amounts falling due after more than one
year:
|
|
|
|
|
|
Provision for tax liability§
|
|
|
(346)
|
|
(834)
|
Net
assets
|
|
|
1,178,171
|
|
1,219,137
|
Capital and
reserves
|
|
|
|
|
|
Share capital
|
8
|
|
1,211,978
|
|
1,213,903
|
Capital reserve
|
|
|
(24,967)
|
|
15,621
|
Capital redemption reserve
|
|
|
4,526
|
|
2,601
|
Revenue reserve
|
|
|
(13,366)
|
|
(12,988)
|
Shareholders'
funds
|
|
|
1,178,171
|
|
1,219,137
|
The accompanying notes below are an integral
part of the Financial Statements.
§ The
tax liability provision at 31 July 2024 relates to a potential
liability for Indian capital gains tax that may arise on the
Company's Indian investments should they be sold in the future,
based on the net unrealised taxable capital gain at the period end
and on enacted Indian tax rates. The amount of any future tax
amounts payable may differ from this provision, depending on the
value and timing of any future sales of such investments and future
Indian tax rates.
Statement of changes in equity (unaudited)
Six months to 31 July 2024
|
Notes
|
Share
capital
US$'000
|
Capital
reserve *
US$'000
|
Capital
redemption
reserve
US$'000
|
Revenue
reserve
US$'000
|
Shareholders'
funds
US$'000
|
Shareholders' funds at 1 February
2024
|
|
1,213,903
|
15,621
|
2,601
|
(12,988)
|
1,219,137
|
Ordinary shares bought back and
cancelled
|
8
|
(1,925)
|
(1,439)
|
1,925
|
-
|
(1,439)
|
Total comprehensive loss for the period -
Ordinary shares
|
|
-
|
(39,149)
|
-
|
(378)
|
(39,527)
|
Shareholders'
funds at 31 July 2024
|
|
1,211,978
|
(24,967)
|
4,526
|
(13,366)
|
1,178,171
|
Six months to 31 July 2023
|
|
Share
capital
US$'000
|
Capital
reserve *
US$'000
|
Capital
redemption
reserve
US$'000
|
Revenue
reserve
US$'000
|
Shareholders'
funds
US$'000
|
Shareholders' funds at 1 February
2023
|
|
1,216,503
|
(51,536)
|
-
|
(11,784)
|
1,153,183
|
Total comprehensive loss for the period -
Ordinary shares
|
|
-
|
(48,168)
|
-
|
(1,483)
|
(49,651)
|
Total comprehensive income for the period - C
sharesâ€
|
|
-
|
1,263
|
-
|
421
|
1,684
|
Shareholders'
funds at 31 July 2023
|
|
1,216,503
|
(98,441)
|
-
|
(12,846)
|
1,105,216
|
*
Includes investment holdings gains of US$1,188,000 (31 July
2023 - losses of US$113,452,000).
†The
C shares converted to Ordinary shares on 8 September 2023 and
therefore there is no C share (loss)/income to report for the six
months to 31 July 2024.
The accompanying notes below are an integral
part of the Financial Statements.
Statement of cash flows (unaudited)
|
Six months to
31 July 2024
|
Six months to
31 July 2023
|
|
US$'000
|
US$'000
|
US$'000
|
US$'000
|
Cash flows
from operating activities
|
|
|
|
|
Operating loss before taxation
|
|
(40,013)
|
|
(47,967)
|
US Treasury Bills interest
|
|
(3,958)
|
|
(2,236)
|
Net losses on investments
|
|
39,662
|
|
46,896
|
Currency (gains)/losses
|
|
(27)
|
|
9
|
Changes in debtors and creditors
|
|
(525)
|
|
(592)
|
Net cash
outflow in operating activities*
|
|
(4,861)
|
|
(3,890)
|
Cash flows
from investing activities
|
|
|
|
|
Acquisitions of US Treasury Bills
|
(78,936)
|
|
(53,111)
|
|
Disposals of US Treasury Bills
|
115,206
|
|
118,826
|
|
Acquisitions of investments
|
(31,782)
|
|
(45,621)
|
|
Disposals of investments
|
9,772
|
|
48,555
|
|
Net cash
inflow from investing activities
|
|
14,260
|
|
68,649
|
Cash flows
from financing activities
|
|
|
|
|
Ordinary shares bought back and
cancelled
|
(1,439)
|
|
-
|
|
Net cash
outflow from financing activities
|
|
(1,439)
|
|
-
|
Net increase
in cash and cash equivalents
|
|
7,960
|
|
64,759
|
Effect of exchange rate fluctuations on cash
and cash equivalents
|
|
27
|
|
(9)
|
Cash and cash equivalents at
1 February
|
|
11,306
|
|
45,799
|
Cash and cash
equivalents at 31 July
|
|
19,293
|
|
110,549
|
*
Cash from operations includes interest received of US$263,000 (2023
- US$878,000).
The accompanying notes below are an integral
part of the Financial Statements.
Notes to the Financial Statements (unaudited)
01 Basis of
accounting
The condensed Financial Statements for the six
months to 31 July 2024 comprises the statements set out above
together with the related notes below. They have been prepared in
accordance with International Financial Reporting Standards (IFRS).
The Financial Statements for the six months to 31 July 2024
have been prepared on the basis of the same accounting policies as
set out in the Company's Annual Report and Financial Statements at
31 January 2024.
Equity investment
The ordinary shares and C shares of the Company
are classified as equity in accordance with the definition of
equity instruments under IAS 32 Financial Instruments: presentation
(IAS 32). The proceeds from the issue of shares are recognised in
the Statement of Changes in Equity net of incremental issuance
costs.
Going concern
In accordance with The Financial Reporting
Council's guidance on going concern and liquidity risk, the
Directors have undertaken a rigorous review of the Company's
ability to continue as a going concern.
In undertaking this review, the Board has
considered the Company's principal risks and uncertainties, as set
out on the inside front cover, and in particular considered the
impact of heightened market volatility due to macroeconomic and
geopolitical concerns, including the Russia-Ukraine war and
heightened tensions between China and both the USA and Taiwan.
Liquidity stress testing has been carried out and having done so
the Board does not believe the Company's going concern status is
affected. The Company maintains sufficient cash balances to enable
it to meet its liabilities as they fall due.
In managing the Company's assets, the
Investment Manager will seek to ensure that the Company holds at
all times a proportion of assets that is sufficiently liquid to
enable it to discharge its payment obligations.
Accordingly, the Financial Statements have been
prepared on the going concern basis as it is the Directors'
opinion, having assessed the principal risks and uncertainties,
that the Company will continue in operational existence for a
period of at least 12 months from the date of approval of these
Financial Statements.
02 Income
|
Six months to 31 July 2024
US$'000
|
Six months to 31 July 2023
US$'000
|
Year to
31 January 2024
US$'000
|
US Treasury Bills interest
|
3,958
|
2,236
|
5,305
|
Overseas interest
|
449
|
398
|
862
|
Deposit interest
|
263
|
878
|
2,044
|
Total
income
|
4,670
|
3,512
|
8,211
|
03 Investment management
fee
|
Six months to 31 July 2024
US$'000
|
Six months to 31 July 2023
US$'000
|
Year to
31 January 2024
US$'000
|
Investment management fee
|
4,471
|
3,937
|
8,152
|
The Company has appointed Baillie Gifford &
Co Limited as its Investment Manager (the 'Investment Manager'). As
the entity appointed to be responsible for risk management and
portfolio management, the Investment Manager has also been
appointed as the Company's Alternative Investment Fund Manager
('AIFM'). Baillie Gifford & Co Limited has delegated portfolio
management services to Baillie Gifford Overseas Limited. The
Investment Management Agreement is terminable on not less than six
months' notice.
Under the terms of the Investment Management
Agreement, the Investment Manager will be entitled to an annual fee
(exclusive of VAT, which shall be added where applicable) of: 0.9%
on the net asset value excluding cash or cash equivalent assets up
to and including US$650 million; 0.8% on the net asset value of the
Company excluding cash or cash equivalent assets exceeding US$650
million up to and including US$1.3 billion; and 0.7% on the net
asset value excluding cash or cash equivalent assets exceeding
US$1.3 billion. Management fees are calculated and payable
quarterly.
Cash equivalents include US Treasury
Bills.
04 Other administrative
expenses
|
Six months to
31 July 2024
US$'000
|
Six months to
31 July 2023
US$'000 *
|
Year to
31 January 2024
US$'000
|
General administrative expenses
|
172
|
228
|
412
|
Administrator's fee
|
48
|
28
|
105
|
Auditor's remuneration for audit
services
|
151
|
154
|
296
|
Directors' fees
|
206
|
227
|
450
|
|
577
|
637
|
1,263
|
*
Expenses relating directly to a share class were charged directly
to that share class. Expenses pertaining to both Ordinary and C
shares were split equally between the share classes.
05 Earnings per
share
|
Six months to
31 July 2024
|
Six months to
31 July 2023
|
Year to
31 January 2024
|
Ordinary
shares
|
US$'000
|
¢
|
US$'000
|
¢
|
US$'000
|
¢
|
Revenue return on ordinary activities after
taxation
|
(378)
|
(0.04)
|
(1,483)
|
(0.30)
|
(1,204)
|
(0.12)
|
Capital return on ordinary activities after
taxation
|
(39,149)
|
(3.81)
|
(48,168)
|
(9.62)
|
69,009
|
6.69
|
Loss/(profit)
and total comprehensive (loss)/income for the
period
|
(39,527)
|
(3.85)
|
(49,651)
|
(9.92)
|
67,805
|
6.57
|
Weighted
average number of Ordinary shares in issue
|
1,028,445,885
|
500,430,002
|
1,032,208,365
|
|
Six months to
31 July 2023
|
C shares*
|
US$'000
|
¢
|
Revenue return on ordinary activities after
taxation
|
421
|
0.06
|
Capital return on ordinary activities after
taxation
|
1,263
|
0.18
|
Profit and
total comprehensive income for the period
|
1,684
|
0.24
|
Weighted
average number of C shares in issue
|
700,000,000
|
Net return per share is based on the above
totals of revenue and capital and the weighted average number of
shares in issue during each period. There are no dilutive or
potentially dilutive shares in issue.
* The
Company's C shares were converted into Ordinary shares on
8 September 2023 and therefore there were no C shares in issue
at 31 January 2024 and 31 July 2024 and no allocable
(loss)/income to report for those periods.
06 Ordinary
dividends
There were no dividends paid or proposed in
respect of the six months to 31 July 2024 (2023 -
nil).
07 Financial
instruments
Fair value hierarchy
The fair value hierarchy used to analyse the
fair values of financial assets is described below. The levels are
determined by the lowest (that is the least reliable or least
independently observable) level of input that is significant to the
fair value measurement for the individual investment in its
entirety as follows:
Level
1 - using unadjusted quoted prices for
identical instruments in an active market;
Level
2 - using inputs, other than quoted prices
included within Level 1, that are directly or indirectly observable
(based on market data); and
Level
3 - using inputs that are unobservable (for
which market data is unavailable).
As at 31 July
2024
|
Level 1 US$'000
|
Level 2 US$'000
|
Level 3 US$'000
|
Total
US$'000
|
Listed equities
|
192,349
|
-
|
-
|
192,349
|
Private company ordinary shares
|
-
|
-
|
209,837
|
209,837
|
Private company preference shares*
|
-
|
-
|
610,144
|
610,144
|
Private company convertible promissory
notes
|
-
|
-
|
13,392
|
13,392
|
Contingent value rightsâ€
|
-
|
-
|
407
|
407
|
Total
financial asset investments
|
192,349
|
-
|
833,780
|
1,026,129
|
As at 31 January
2024
|
Level 1 US$'000
|
Level 2 US$'000
|
Level 3 US$'000
|
Total
US$'000
|
Listed equities
|
173,665
|
-
|
-
|
173,665
|
Private company ordinary shares
|
-
|
-
|
172,693
|
172,693
|
Private company preference shares*
|
-
|
-
|
684,298
|
684,298
|
Private company convertible promissory
notes
|
-
|
-
|
12,718
|
12,718
|
Contingent value rightsâ€
|
-
|
-
|
407
|
407
|
Total
financial asset investments
|
173,665
|
-
|
870,116
|
1,043,781
|
* The
investments in preference shares are not classified as equity
holdings as they include liquidation preference rights that
determine the repayment (or multiple thereof) of the original
investment in the event of a liquidation event such as a
take-over.
†See
Glossary of terms and Alternative Performance Measures
below.
During the six months to 31 July 2024, the
investment in Tempus AI with a fair value (IPO price) of
US$32,553,000 was transferred from Level 3 to Level 1 on becoming
listed.
During the year to 31 January 2024, the
investment in Oddity with a fair value (IPO price) of US$11,800,000
was transferred from Level 3 to Level 1 on becoming
listed.
The valuation techniques used by the Company
are explained in the accounting policies on pages 85 and 86 of the
Company's Annual Report and Financial Statements for the year to
31 January 2024. Listed investments are categorised as Level 1
if they are valued using unadjusted quoted prices for identical
instruments in an active market and as Level 2 if they do not meet
all these criteria but are, nonetheless, valued using market data.
The Company's holdings in unlisted investments are categorised as
Level 3 unobservable data is a significant input to their fair
value measurements.
08 Share
capital
|
31 July
2024
Number
|
31 July
2024
US$'000
|
31 January
2024
Number
|
31 January
2024
US$'000
|
Allotted, called up and fully paid Ordinary
shares of US$1 each
|
1,027,973,907
|
1,211,978
|
1,029,898,907
|
1,213,903
|
By way of a Special Resolution passed on
10 May 2024 the Directors of the Company were granted a
general authority to allot or sell from treasury, without regard to
the pre-emption rights contained in the Articles of Incorporation
of the Company, up to 102,882,390 Ordinary shares or C shares (as
defined in the Articles of Incorporation). This authority will
expire at the end of the period concluding immediately prior to the
Annual General Meeting of the Company to be held in 2029 (or, if
earlier, five years from the date of the passing of the
resolution).
During the six months to 31 July 2024 the
Company did not issue any Ordinary shares or C shares. In the
period from 1 August 2024 to 10 September 2024 the
Company issued no Ordinary shares or C shares.
By way of a Special Resolution passed on
10 May 2024 the Directors of the Company have general
authority to make market purchases of up to 154,145,753 Ordinary
shares, being 14.99% of the Ordinary shares in issue as at
10 May 2024, being the date of the passing of the resolution.
This authority will expire at the conclusion of the Annual General
Meeting of the Company to be held in respect of the year ending
31 January 2025.
1,925,000 Ordinary shares were bought back
during the six months to 31 July 2024 (31 July 2023 -
nil). In the period from 1 August 2024 to 10 September
2024 200,000 Ordinary shares were bought back.
Holders of Ordinary shares have the right to
receive income and capital from assets attributable to such share
class. Ordinary shareholders have the right to receive notice of
general meetings of the Company and have the right to attend and
vote at all general meetings.
09 Transactions with
related parties and the investment manager and
administrator
There have been no transactions with related
parties during the first six months of the current financial year
that have materially affected the financial position or the
performance of the Company during that period and there have been
no changes in the related party transactions described in the last
Annual Report and Financial Statements that could have such an
effect on the Company during that period.
Further shareholder information
Automatic Exchange of Information
In order to fulfil its legal obligations under
the Guernsey Common Reporting Standard Legislation relating to the
Automatic Exchange of Information, the Company is required to
collect and report certain information about certain
shareholders.
The legislation will require investment
companies to provide personal information to the Guernsey
authorities on certain investors who purchase shares in investment
funds. As an affected company, The Schiehallion Fund Limited will
have to provide information annually to the local authority on the
tax residencies of non-UK based certificated shareholders and
corporate entities.
Foreign Account Tax Compliance Act
Pursuant to the reciprocal information sharing
inter-governmental agreement entered into by the States of Guernsey
and the US Treasury, and for the purposes of the US Foreign Account
Tax Compliance Act ('FATCA') of the Company registered with
the Internal Revenue Service ('IRS') as a Foreign Financial
Institution ('FFI') and received a Global Intermediary
Identification Number (R2NXXB.9999.SL.831). The Company can be
located on the IRS FFI list.
Third party data providers disclaimer
No third party data provider ('Provider') makes
any warranty, express or implied, as to the accuracy, completeness
or timeliness of the data contained herewith nor as to the results
to be obtained by recipients of the data. No Provider shall in any
way be liable to any recipient of the data for any inaccuracies,
errors or omissions in the index data included in this document,
regardless of cause, or for any damages (whether direct or
indirect) resulting therefrom.
No Provider has any obligation to update,
modify or amend the data or to otherwise notify a recipient thereof
in the event that any matter stated herein changes or subsequently
becomes inaccurate.
Without limiting the foregoing, no Provider
shall have any liability whatsoever to you, whether in contract
(including under an indemnity), in tort (including negligence),
under a warranty, under statute or otherwise, in respect of any
loss or damage suffered by you as a result of or in connection with
any opinions, recommendations, forecasts, judgements, or any other
conclusions, or any course of action determined, by you or any
third party, whether or not based on the content, information or
materials contained herein.
Glossary of terms and Alternative Performance Measures
('APM')
An alternative performance measure is a
financial measure of historical or future financial performance,
financial position, or cash flows, other than a financial measure
defined or specified in the applicable financial reporting
framework.
Shareholders' funds and Net Asset Value
Shareholders' Funds is the value of all assets
held less all liabilities, with borrowings deducted at book cost.
Net Asset Value (NAV) is the value of all assets held less all
liabilities, with borrowings deducted at either fair value or par
value. Per share amounts are calculated by dividing the relevant
figure by the number of ordinary shares in issue.
Total Return
The total return is the return to shareholders
after reinvesting the net dividend on the date that the share price
goes ex-dividend. The Company does not pay a dividend, therefore,
the total returns for the share price and NAV per share are the
same as the percentage movements in the share price and NAV per
share as detailed above.
Capital deployed (APM)
Capital deployed reflects cumulative amounts
invested since inception of the Company.
Contingent value rights
'CVR' after an instrument name indicates a
security, usually arising from a corporate action such as a
takeover or merger, which represents a right to receive potential
future value, should the continuing company achieve certain
milestones.
Total net assets
Total value of all assets held less current
liabilities, other than liabilities in the form of
borrowings.
Net current assets
Net current assets comprise current assets less
current liabilities (excluding borrowings).
(Discount)/premium (APM)
As stock markets and share prices vary, an
investment company's share price is rarely the same as its NAV.
When the share price is lower than the NAV per share it is said to
be trading at a discount. The size of the discount is calculated by
subtracting the share price from the NAV per share and is usually
expressed as a percentage of the NAV per share. If the share price
is higher than the NAV per share, it is said to be trading at a
premium.
Ordinary
shares
|
|
31 July
2024
|
31 January
2024
|
Closing NAV per share
|
(a)
|
114.61¢
|
118.37¢
|
Closing share price
|
(b)
|
103.00¢
|
71.50¢
|
Discount
expressed as a percentage
|
(b - a) ÷ a
|
(10.1%)
|
(39.6%)
|
None of the views expressed in this document
should be construed as advice to buy or sell a particular
investment.
You can find up to date performance information
about The Schiehallion Fund on the Company website at schiehallionfund.com‡
The Schiehallion Fund Limited is managed by
Baillie Gifford, the Edinburgh based fund management group with
around £207.8 billion under management and advice in active equity
and bond portfolios for clients in the UK and throughout the world
(as at 10 September 2024). The Administrator, Secretary and
Designated Manager is Alter Domus (Guernsey) Limited.
‡ Neither the contents of the Managers' website
nor the contents of any website accessible from hyperlinks on the
Managers' website (or any other website) is incorporated into, or
forms part of, this announcement.
Past performance is not a guide to future
performance. The value of an investment and any income from
it is not guaranteed and may go down as well as up and investors
may not get back the amount invested. This is because the
share price is determined by the changing conditions in the
relevant stock markets in which the Company invests and by the
supply and demand for the Company's shares.
13 September 2024
For further information please
contact:
Alex Blake, Baillie Gifford & Co
Tel: 0131 275 2000
Jonathan Atkins, Four Communications
Tel: 0203 920 0555 or 07872 495396
- ends -